| 000 | 01365 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517200416.0 | ||
| 264 | 0 | _c20181115 | |
| 008 | 201811s 0 0 chi d | ||
| 022 | _a1009-2137 | ||
| 024 | 7 |
_a10.7534/j.issn.1009-2137.2018.01.031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Jing-Dong | |
| 245 | 0 | 0 |
_a[Change of Neutrophils/ Lymphocyte Ratio in Patients with DLBCL before and after CHOP or R-CHOP Chemotherapy and Its Effect on Survival of Patients]. _h[electronic resource] |
| 260 |
_bZhongguo shi yan xue ye xue za zhi _cFeb 2018 |
||
| 300 |
_a182-186 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 | _aCyclophosphamide |
| 650 | 0 | 4 | _aDoxorubicin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocytes |
| 650 | 0 | 4 | _aLymphoma, Large B-Cell, Diffuse |
| 650 | 0 | 4 | _aNeutrophils |
| 650 | 0 | 4 | _aPrednisone |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aVincristine |
| 700 | 1 | _aHan, Xiao-Lin | |
| 700 | 1 | _aYang, Cui | |
| 700 | 1 | _aSun, Ling | |
| 773 | 0 |
_tZhongguo shi yan xue ye xue za zhi _gvol. 26 _gno. 1 _gp. 182-186 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7534/j.issn.1009-2137.2018.01.031 _zAvailable from publisher's website |
| 999 |
_c28041426 _d28041426 |
||